Clinical trial / 2009
Active vitamin D linked to short-term bone marker improvements in Crohn's disease
A prospective study followed 37 inactive Crohn's disease patients in two matched groups receiving either active or plain vitamin D. At six weeks, the active form was linked to lower disease activity index values (69.44 vs 57.0) and C-reactive protein (15.8 vs 7.81 mmol/L, P < 0.05). Markers of bone turnover also decreased and osteoprotegerin rose with the active form. These biochemical changes were stronger at three months but disappeared by month 12.
- Study type
- Prospective comparative study with matched groups
- Who was studied
- 37 inactive Crohn's disease patients
- What was measured
- Bone turnover markers and Crohn's disease activity
THE PAPER
Comparison of the effects of 1,25 dihydroxyvitamin D and 25 hydroxyvitamin D on bone pathology and disease activity in Crohn's disease patients.
Miheller P, Muzes G, Hritz I, Lakatos G, Pregun I, Lakatos PL, Herszényi L, Tulassay Z. Inflamm Bowel Dis, 2009.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.